DeepSeek-R1 offers promising potential to accelerate healthcare transformation
- Details
- Category: Research
Sevabertinib (BAY 2927088) granted FDA Priority Review for the treatment of patients with HER2-mutant non-small cell lung cancer
- Details
- Category: Bayer

Researchers identify drug candidate for difficult-to-treat heart disease
- Details
- Category: Research
Potential new treatment for Alzheimer's disease, other neurodegenerative conditions
- Details
- Category: Research
While there is no treatment to control or manage these neurodegenerative conditions, investigators at Case Western Reserve University, University Hospitals and the Louis Stokes Cleveland VA Medical Center have identified a new and promising drug to treat AD.
Common antidepressants could help the immune system fight cancer
- Details
- Category: Research
Selective serotonin reuptake inhibitors, or SSRIs, significantly enhanced the ability of T cells to fight cancer and suppressed tumor growth across a range of cancer types in both mouse and human tumor models, the study, published in Cell, found.
Pfizer enters into exclusive licensing agreement with 3SBio
- Details
- Category: Pfizer

Candidate drug that boosts protective brain protein in mice has potential to treat Alzheimer's disease
- Details
- Category: Research
In a study published in the Nature journal npj Drug Discovery, UCLA Health researchers targeted the protein clusterin (CLU), which is crucial in preventing the build-up of amyloid-beta plaques and
Purdue center offers first comprehensive open access database of all clinically tested drugs
- Details
- Category: Development
The center, or CRIB, is a collaborative effort between Purdue and Stony Brook universities.
Diabetes drug gives hope for new treatment for prostate cancer
- Details
- Category: Research
Generative AI on track to shape the future of drug design
- Details
- Category: Research
In a new paper, Xia Ning, lead author of the study and a professor of biomedical informatics and computer science and engineering at The Ohio State University, introduces DiffSMol, a generative AI model capable of generating realistic 3D structures of small molecules that can serve as promising drug candidates.